DEB-TACE (drug-eluting bead transarterial chemoembolization)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for DEB-TACE (drug-eluting bead transarterial chemoembolization), covering 2025-02-14 to 2025-02-14. Get the full timeline:
Most recent: Clinical Trial Update: A Clinical Study of DEB-TACE Combined With Surufatinib and Camrelizumab in the Treatment of Inoperable or Metastatic ICC [Phase 2]